abagovomab 47
abciximab 41
abituzumab 35
abrilumab 25
actoxumab 28
adalimumab 20
aducanumab 19
afasevikumab 16
alacizumab_pegol 14
alemtuzumab 40
alirocumab 19
amatuximab 54
andecaliximab 33
anifrolumab 28
anrukinzumab 20
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 25
ascrinvacumab 21
atezolizumab 15
atinumab 21
avelumab 17
basiliximab 53
bavituximab 47
begelomab 44
benralizumab 33
bevacizumab_beta 24
bezlotoxumab 28
bimagrumab 25
bleselumab 32
blinatumomab 51
blosozumab 42
bococizumab 31
brazikumab 23
brentuximab_vedotin 46
briakinumab 24
brodalumab 31
brolucizumab 32
brontictuzumab 37
burosumab 38
cabiralizumab 41
camrelizumab 16
canakinumab 24
cantuzumab_ravtansin 52
carlumab 28
carotuximab 21
cergutuzumab_amunaleukin2 36
cergutuzumab_amunaleukin 36
certolizumab_pegol 29
cetiximab 44
citatuzumab_bogatox 34
cixutumumab 48
clivatuzumab_tetraxetan 35
codrituzumab 26
conatumumab 26
concizumab 22
crenezumab 20
crizanlizumab 34
crotedumab 28
dacetuzumab 24
daclizumab 27
dalotuzumab 39
dapirolizumab_pegol 29
daratumumab 16
dectrekumab 15
demcizumab 41
denosumab 8
depatuxizumab 34
depatuxizumab_mafodotin 34
dezamizumab 35
dinutuximab 45
diridavumab 32
domagrozumab 18
drozitumab 21
duligotuzumab 21
durvalumab 17
dusigitumab 36
efalizumab 39
efungumab 27
eldelumab 20
elezanumab 37
elgemtumab 13
elotuzumab 22
emactuzumab 36
emapalumab 29
emibetuzumab 33
enavatuzumab 28
enfortumab_vedotin 17
enoblituzumab 23
enokizumab 36
enoticumab 27
ensituximab 42
eptinezumab 19
erenumab 31
etaracizumab 17
etrolizumab 25
evinacumab 24
evolocumab 35
farletuzumab 7
fasinumab 33
fezakinumab 37
fibatuzumab 30
ficlatuzumab 37
firivumab 36
flanvotumab 28
fletikumab 43
foralumab 19
foravirumab 20
fremanezumab 32
fresolimumab 26
fulranumab 25
futuximab 36
galcanezumab 26
ganitumab 32
gantenerumab 16
gemetuzumab 36
gemtuzumab2 38
gemtuzumab 35
gevokizumab 34
girentuximab 35
glembatumumab 32
glembatumumab_vedotin 32
guselkumab 33
ibalizumab 37
ibritumomab 48
icrucumab 16
idarucizumab 43
ifabotuzumab 30
imalumab 15
imgatuzumab 36
inclacumab 26
indatuximab_ravtansin 40
indusatumab 30
inebilizumab 30
intetumumab 20
iodine_girentuximab 33
ipilimumab 5
iratumumab 26
isatuximab 45
itolizumab 32
ixekizumab 36
labetuzumab_govitecan 28
lambrolizumab 42
lampalizumab 29
lanadelumab 22
landogrozumab 22
laprituximab 38
lebrikizumab 40
lendalizumab 38
lenzilumab 33
lifastuzumab_vedotin 26
ligelizumab 35
lilotomab 41
lirilumab 38
lodelcizumab 32
lokivetmab 24
lorvotuzumab_mertansin 24
lucatumumab 33
lumretuzumab 31
lupartumab 20
lutikizumab 18
margetuximab 40
milatuzumab 36
mirvetuximab 50
mirvetuximab_soravtansin 50
modotuximab 58
mogamulizumab 24
monalizumab 36
motavizumab 37
moxetumomab_pasudotox 25
namilumab 37
naratuximab 47
naratuximab_emtansin 47
narnatumab 22
navicixizumab2 31
navicixizumab 42
navivumab 47
necitumumab 28
nemolizumab 35
nesvacumab 14
nivolumab 21
obiltoxaximab 27
obinutuzumab 38
ocaratuzumab 35
ofatumumab 20
olaratumab 38
olokizumab 28
omalizumab 24
onartuzumab 24
ontuxizumab 34
opicinumab 16
orticumab 15
otelixizumab 40
oxelumab 13
ozanezumab 32
pamrevlumab 16
panobacumab 20
parsatuzumab 34
pasotuxizumab 19
pateclizumab 23
patritumab 34
pembrolizumab 42
perakizumab 25
pidilizumab 20
pinatuzumab_vedotin 21
plozalizumab 28
pogalizumab 37
polatuzumab_vedotin 24
ponezumab 44
prezalumab 18
pritoxaximab 51
quilizumab 20
racotumomab 42
radretumab 19
ralpancizumab 35
ramucirumab 20
ranevetmab 32
ranibizumab 23
refanezumab 28
remtolumab 21
rilotumumab 32
rinucumab 28
risankizumab 39
rituximab 37
rivabazumab 26
robatumumab 22
roledumab 31
romosozumab 37
rontalizumab 28
rosmantuzumab 35
rozanolixizumab 24
sacituzumab 34
sacituzumab_govitecan 34
samalizumab 40
sapelizumab 34
sarilumab 22
secukinumab 24
seribantumab 20
setoxaximab 46
sifalimumab 23
siltuximab 29
simtuzumab 40
sirukumab 16
solanezumab 29
solitomab 34
stamulumab 35
suptavumab 31
suvizumab 22
tabalumab 33
tadocizumab 28
tamtuvetmab 34
tanezumab 33
tarextumab 14
tavolixizumab 26
telisotuzumab 43
teplizumab 24
tesidolumab 36
tezepelumab 30
tigatuzumab 16
tildrakizumab 34
timolumab 19
tisotumab 15
tosatoxumab 40
tositumomab 45
tralokinumab 44
trastuzumab 27
tregalizumab 25
trevogrumab 16
ublituximab 41
urelumab 32
ustekinumab 35
utomilumab 35
vadastuximab 41
vadastuximab_talirin 41
vandortuzumab_vedotin 24
vantictumab 29
vanucizumab2 24
vanucizumab 53
varlilumab 21
vatelizumab 38
vedolizumab 38
veltuzumab 29
vesencumab 15
vorsetuzumab 38
vorsetuzumab_mafodotin 38
vunakizumab 41
xentuzumab 23
zatuximab 58
